Testosterone Replacement Therapy and Cardiovascular Risk: A Review
Recent reports in the scientific and lay press have suggested that testosterone (T) replacement therapy (TRT) is likely to increase cardiovascular (CV) risk. In a final report released in 2015, the Food and Drug Administration (FDA) cautioned that prescribing T products is approved only for men who...
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Korean Society for Sexual Medicine and Andrology
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709429/ |